Innovative radiopharmaceuticals in cancer diagnostics and radionuclide therapy-Reference-Cited by-同舟云学术

Innovative radiopharmaceuticals in cancer diagnostics and radionuclide therapy

Published:2024-07-04 Issue:1 Volume:94 Page:66-79
ISSN:0869-5873
Container-title:Вестник Российской академии наук
language:
Short-container-title:Vestnik Rossijskoj akademii nauk

Author:

Chernov V. I.¹²

Affiliation:

1. Cancer Research Institute — branch of the Tomsk National Research Medical Center of the Russian Academy of Sciences

2. Tomsk Polytechnic University

Abstract

The article presents the development trends of nuclear medicine in oncology. It has been shown that the main trends in modern radiopharmaceutics are closely related to theranostics, i.e., the use of radiopharmaceuticals obtained on the basis of a single delivery vector labeled with diagnostic and therapeutic radionuclides. In nuclear medicine, this approach has found application for the individualization and planning of radionuclide therapy. The results of our own research aimed at the development of radiopharmaceuticals for the diagnosis and radionuclide therapy of cancer are presented.

Publisher

The Russian Academy of Sciences

Reference48 articles.

1. Состояние онкологической помощи населению России в 2019 году // Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена, 2020.

2. Национальное руководство по радионуклидной диагностике. В 2 т. // Под ред. Ю.Б. Лишманова, В.И. Чернова. Томск: STT, 2010.

3. Tolmachev V.M., Chernov V.I., Deyev S.M. Targeted nuclear medicine. See and destroy // Russ. Chem. Rev. 2022. V. 91. RCR5034.

4. Чернов В.И., Медведева А.А., Синилкин И.Г. и др. Ядерная медицина в диагностике и адресной терапии злокачественных новообразований // Бюллетень сибирской медицины. 2018. Т. 17 (1). С. 220–231.

5. Wester H.J., Kessler H. Molecular Targeting with Peptides or Peptide-Polymer Conjugates: Just a Question of Size? // Journal of Nuclear Medicine December. 2005. V. 46 (12). P. 1940–1945.